Effect of postoperative scheduled intravenous acetaminophen in patients undergoing lhead and neck tumorsurgery

Phase 2

• Conditions: head and neck tumor; parotid gland tumor, thyroid tumor; D010307, D013964

• Registration Number: JPRN-jRCT1041230004
• Lead Sponsor: Endo Kazuhira

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-04-08
• Last Update Posted: 1 April 2024

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

head and neck tumor
Surgery case under general anesthesia
20 years of age or older
Performance Status (ECOG) is 0 or 1
After obtaining informed consent for participation in the clinical research, the patient's voluntary written consent has been obtained

Exclusion Criteria

Patients with a history of allergy to acetaminophen in the past
Patients with aspirin asthma
Patients with liver dysfunction and thrombocytopenia
Patients who indicated their intention to refuse to participate before regular administration of Acerio
Patients who are judged to be unsuitable as subjects by the judgment of a doctor

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain VAS score (on the day of surgery, postoperative days 1 and 2)

Secondary Outcome Measures

Name	Time	Method
ength of hospital stay, postoperative oral intake (average of staple food and side dish), number of times of use of NSAIDs until postoperative day 2, adverse events